SCHEMBL3924693

SCHEMBL3924693

CN1CCCC(CNC=O)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 2/20 0.57
ADH1C P00326 2/20 0.57
ADH1A P07327 2/20 0.57
ADH7 P40394 2/20 0.57
ADH4 P08319 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.35
KCNH2 Q12809 3/20 0.35
CHRM2 P08172 2/20 0.35
ADRA2A P08913 2/20 0.35
CHRM1 P11229 2/20 0.35
DRD1 P21728 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
ADRA1A P35348 2/20 0.35
OPRM1 P35372 2/20 0.35
DRD3 P35462 2/20 0.35
HRH3 Q9Y5N1 2/20 0.35
LMNA P02545 2/20 0.35
ABCB11 O95342 1/20 0.35
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510986 1.00 ADH1B (0.57) ADH1BADH1CADH1AADH7ADH4
SCHEMBL3927921 0.89 ADH1B (0.50) ADH1BADH1CADH1AADH7ADH4
SCHEMBL3928885 0.81 ADH1B (0.52) ADH1BADH1CADH1AADH7ADH4
SCHEMBL4874323 0.80 SMN1; SMN2 (0.37) ADH1BADH1CADH1AADH7ADH4
SCHEMBL3318099 0.80 ADH1B (0.50) ADH1BADH1CADH1AADH7ADH4
SCHEMBL3316370 0.80 ADH1B (0.50) ADH1BADH1CADH1AADH7ADH4
SCHEMBL3317295 0.80 ADH1B (0.50) ADH1BADH1CADH1AADH7ADH4
SCHEMBL1911418 0.79 ADH1B (0.57) ADH1BADH1CADH1AADH7ADH4
SCHEMBL1608989 0.77
SCHEMBL9962292 0.77 SAT1 (0.38) SMN1; SMN2KCNH2CHRM2ADRA2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235384-A1 COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME SANOFI US SERVICES INC. (US) 2023-12-07 WO disclosed
EP-3319960-B1 PYRIMIDINE DERIVATIVES AS BTK INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2020-11-18 EP disclosed
WO-2009007390-A2 2-PYRAZ INYLBENZ IMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-01-15 WO disclosed